文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

快速序贯器官衰竭评分与改良早期预警评分在脓毒症院前预后预测中的作用

The role of the quick sequential organ failure assessment score (qSOFA) and modified early warning score (MEWS) in the pre-hospitalization prediction of sepsis prognosis.
PubMed 文献 · Am J Emerg Med · 2020-09-30
一句话结论对已诊断脓毒症的院前患者,qSOFA预测ICU入住和28天死亡的价值高于MEWS。

该回顾性研究纳入2017年1月至2019年12月经救护车送至急诊并诊断为脓毒症的266例患者,从院前交接单记录生命体征并计算qSOFA和MEWS。高MEWS组死亡率约为低MEWS组的1.24倍(95%CI 1.110-1.385),高qSOFA组约为低qSOFA组的2.0倍(95%CI 1.446-2.693)。高MEWS组需ICU住院的风险为低MEWS组的1.34倍(95%CI 1.1773-1.5131),高qSOFA组为低qSOFA组的3.21倍(95%CI 2.2289-4.6093)。作者认为qSOFA在院前脓毒症预后判断中比MEWS更有价值。

要点

  • 已诊断脓毒症的院前患者中,高qSOFA评分者28天死亡风险约为低qSOFA者的2.0倍(95%CI 1.446-2.693)。
  • 高qSOFA评分者需ICU住院的风险约为低qSOFA者的3.21倍(95%CI 2.2289-4.6093)。
  • 高MEWS评分者28天死亡风险约为低MEWS者的1.24倍(95%CI 1.110-1.385)。
  • 高MEWS评分者需ICU住院的风险约为低MEWS者的1.34倍(95%CI 1.1773-1.5131)。
  • 作者认为qSOFA在院前脓毒症预后判断中比MEWS更有价值。

适用人群与场景

  • 2017年1月至2019年12月经救护车送至Dışkapı YıldırımBeyazıt培训与研究医院急诊并诊断为脓毒症、收住院的患者。

研究设计与关键结果

  • 回顾性研究,纳入266例脓毒症患者,50%(n=133)为女性,平均年龄74.8±13岁。
  • 高MEWS组与低MEWS组、高qSOFA组与低qSOFA组的ICU入住率和死亡率差异均有统计学意义(p<0.05)。
  • 高MEWS组死亡率约为低MEWS组的1.24倍(p<0.001,95%CI 1.110-1.385)。
  • 高qSOFA组死亡率约为低qSOFA组的2.0倍(p<0.001,95%CI 1.446-2.693)。
  • 高MEWS组需ICU住院的风险为低MEWS组的1.34倍(p<0.001,95%CI 1.1773-1.5131)。
  • 高qSOFA组需ICU住院的风险为低qSOFA组的3.21倍(p<0.001,95%CI 2.2289-4.6093)。

证据类型、等级与局限

  • 回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,已诊断脓毒症的患者可在住院前用qSOFA和MEWS评估以预测ICU住院和死亡,且qSOFA在院前脓毒症预后判断中比MEWS更有价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Many biomarkers and scoring systems to make clinical predictions about the prognosis of sepsis have been investigated. In this study, we aimed to assess the use of the quick sequential organ failure assessment score (qSOFA) and modified early warning score (MEWS) scoring systems in emergency health care services for sepsis to predict intensive care hospitalization and 28-day mortality.

METHOD: Patients who arrived by ambulance at the Emergency Department (ED) of Dışkapı YıldırımBeyazıt Training and Research Hospital between January 2017 and December 2019, and who were diagnosed with sepsis and admitted to the hospital were included in the study. Demographic data and physiological parameters from 112 ambulance case delivery forms were recorded.QSOFA and MEWS scores were calculated from vital parameters.

RESULTS: Of the 266 patients diagnosed with sepsis, 50% (n = 133) were female, and the mean age was 74.8 ± 13. The difference between the rate of intensive care (ICU) hospitalization and mortality for patients with a high MEWS and qSOFA score and patients whose MEWS and qSOFA score were lower was found to be statistically significant (p < 0.05). Thus, the criteria for MEWS and qSOFA could determine ICU hospitalization and early mortality. Those with a high MEWS value had a mortality rate approximately 1.24 times higher than those with a low MEWS value (p < 0.001, 95% CI: 1.110-1.385), while those with a high qSOFA score had a mortality rate approximately 2.0 times higher than those with a low qSOFA score (p < 0.001, 95% CI: 1.446-2.693). Those with a high MEWS were 1.34 times more likely than hose with a lower MEWS to require ICU hospitalization (p < 0.001, 95% CI: 1.1773-1.5131), while patients with a high qSOFA score were 3.21 times more likely than those with a lower qSOFA score to require ICU care (p < 0.001, 95% CI: 2.2289-4.6093).

CONCLUSION: Although qSOFA and MEWS are clinical scores used to identify septic patients outside the critical care unit, we believe that patients already diagnosed with sepsis can be assessed with qSOFA and MEWS prior to hospitalization to predict intensive care hospitalization and mortality. qSOFA was found be more valuable than MEWS in determining the prognosis of pre-hospitalization sepsis.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Usul E, Korkut S, Kayipmaz AE, et al. The role of the quick sequential organ failure assessment score (qSOFA) and modified early warning score (MEWS) in the pre-hospitalization prediction of sepsis prognosis. Am J Emerg Med. 2020. PMID: 33071081. doi:10.1016/j.ajem.2020.09.049

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。